IGFBP7 and breast carcinoma: Congruently, increased VEGF levels were recorded in lung tumors of IGFBP7−/− mice (Akiel et al., 2017) and administration of exogenous IGFBP7 reduced VEGF expression in breast cancer cell lines 1833 xenografts implanted in mice (Benatar et al., 2012).